Galena Biopharma, Inc. (GALE)
-NasdaqCM 2.08 
0.03(1.42%) 4:00PM EDT
| Prev Close: | 2.11 |
|---|
| Open: | 2.15 |
|---|
| Bid: | 2.02 x 100 |
|---|
| Ask: | 2.32 x 100 |
|---|
| 1y Target Est: | 5.06 |
|---|
| Beta: | 1.59 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 2.06 - 2.16 |
|---|
| 52wk Range: | 1.23 - 3.00 |
|---|
| Volume: | 873,645 |
|---|
| Avg Vol (3m): | 2,081,090 |
|---|
| Market Cap: | 173.60M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.27 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 5 Stocks Under $10at Motley Fool(Mon, Jun 17)
- 2 Drugs With Acquisition Potentialat Motley Fool(Wed, Jun 5)
- GALE Is Making Progresses in its Three Clinical ProgramsZacks Small Cap Research(Tue, Jun 4)
- Galena Biopharma provides product pipeline update at ASCO annual meetingat theflyonthewall.com(Mon, Jun 3)
- Galena Biopharma Provides Product Pipeline Update at the ASCO 2013 Annual MeetingGlobeNewswire(Mon, Jun 3)
- GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibEDGAR Online(Fri, May 31)
- Galena Biopharma to Present at the Jefferies 2013 Global Healthcare ConferenceGlobeNewswire(Thu, May 30)
- Galena Biopharma to Present at the 2013 Marcum MicroCap ConferenceGlobeNewswire(Thu, May 23)
- A Journey To Add Biotech To The Portfolioat Seeking Alpha(Sat, May 18)
- GALENA BIOPHARMA, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- GALENA BIOPHARMA, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and ExEDGAR Online(Thu, May 16)
- Galena Targets Cancer Pain Marketat Seeking Alpha(Wed, May 15)
- Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaningat Seeking Alpha(Wed, May 15)
- Galena Biopharma: Stock First, Science Second?at Seeking Alpha(Mon, May 13)
- VIDEO RELEASE -- Galena Biopharma Reports First Quarter 2013 Financial ResultsGlobeNewswire(Thu, May 9)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.42 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.10 |
|---|
| Mean Recommendation*: | 1.9 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care.
View More